Effect of ADP-induced shape change on incorporation of 32P into platelet phosphatidic acid and mono-, di- and triphosphatidyl inositol.
D000244:Adenosine Diphosphate / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D002118:Calcium / Q000494:pharmacology; D000242:Cyclic AMP / Q000494:pharmacology; D004987:Ethers / Q000494:pharmacology; D005340:Fibrinogen / Q000494:pharmacology; D006801:Humans; D007094:Imides / Q000494:pharmacology; D066298:In Vitro Techniques; D010710:Phosphates / Q000378:metabolism*; D010716:Phosphatidylinositols / Q000096:biosynthesis*; D010743:Phospholipids / Q000096:biosynthesis*; D010759:Phosphorus Isotopes; D010973:Platelet Adhesiveness / Q000187:drug effects; D011453:Prostaglandins / Q000494:pharmacology; D011817:Rabbits; D013268:Stimulation, Chemical; D013552:Swine
D004987:Ethers; D007094:Imides; D010710:Phosphates; D010716:Phosphatidylinositols; D010743:Phospholipids; D010759:Phosphorus Isotopes; D011453:Prostaglandins; D000244:Adenosine Diphosphate; D005340:Fibrinogen; D000242:Cyclic AMP; D002118:Calcium